Search Orphan Drug Designations and Approvals
-
| Generic Name: | recombinant adeno-associated virus 5 vector expressing a functional human cyclic nucleotide gated channel subunit beta 1 (CNGB1) gene |
|---|---|
| Date Designated: | 09/23/2024 |
| Orphan Designation: | treatment of autosomal recessive retinitis pigmentosa due to CNGB1 mutations |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
National Institutes of Health National Institutes of Health (NIH), National Center for Advancing Translational Sciences (NCATS) 9609 Medical Center Drive, Suite 1-E-162 Rockville, Maryland 20850 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







